Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 20;401(10389):1669-1680.
doi: 10.1016/S0140-6736(23)00811-5. Epub 2023 Apr 20.

Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study

Affiliations

Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study

Christian Rosas-Salazar et al. Lancet. .

Abstract

Background: Early-life severe respiratory syncytial virus (RSV) infection has been associated with the onset of childhood wheezing illnesses. However, the relationship between RSV infection during infancy and the development of childhood asthma is unclear. We aimed to assess the association between RSV infection during infancy and childhood asthma.

Methods: INSPIRE is a large, population-based, birth cohort of healthy infants with non-low birthweight born at term between June and December, 2012, or between June and December, 2013. Infants were recruited from 11 paediatric practices across middle Tennessee, USA. We ascertained RSV infection status (no infection vs infection) in the first year of life using a combination of passive and active surveillance with viral identification through molecular and serological techniques. Children were then followed up prospectively for the primary outcome of 5-year current asthma, which we analysed in all participants who completed 5-year follow-up. Statistical models, which were done for children with available data, were adjusted for child's sex, race and ethnicity, any breastfeeding, day-care attendance during infancy, exposure to second-hand smoke in utero or during early infancy, and maternal asthma.

Findings: Of 1946 eligible children who were enrolled in the study, 1741 (89%) had available data to assess RSV infection status in the first year of life. The proportion of children with RSV infection during infancy was 944 (54%; 95% CI 52-57) of 1741 children. The proportion of children with 5-year current asthma was lower among those without RSV infection during infancy (91 [16%] of 587) than those with RSV infection during infancy (139 [21%] of 670; p=0·016). Not being infected with RSV during infancy was associated with a 26% lower risk of 5-year current asthma than being infected with RSV during infancy (adjusted RR 0·74, 95% CI 0·58-0·94, p=0·014). The estimated proportion of 5-year current asthma cases that could be prevented by avoiding RSV infection during infancy was 15% (95% CI 2·2-26·8).

Interpretation: Among healthy children born at term, not being infected with RSV in the first year of life was associated with a substantially reduced risk of developing childhood asthma. Our findings show an age-dependent association between RSV infection during infancy and childhood asthma. However, to definitively establish causality, the effect of interventions that prevent, delay, or decrease the severity of the initial RSV infection on childhood asthma will need to be studied.

Funding: US National Institutes of Health.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests LJA has served on RSV vaccine advisory boards for Bavarian Nordic, Novavax, Daiichi-Sankyo, ClearPath Development Company, ADVI, Pfizer, and Jansen Pharmaceuticals. Through Emory University, LJA's laboratory currently receives funding from Pfizer for RSV surveillance studies in adults, from Advaccine Biopharmacueticals Suzhou for serological studies of RSV vaccine recipients, and from Sciogen for animal studies on RSV vaccines. LJA is a co-inventor on several Centers for Disease Control and Prevention patents on the RSV G protein and its CX3C chemokine motif relative to immune therapy and vaccine development. LJA is also co-inventor on a patent filing for the use of RSV platform virus-like particles with the F protein and G protein for vaccines. TVH has served on a data safety monitoring board for Pfizer and RSV vaccine advisory boards for Sanofi-Pasteur and Pfizer. All other authors declare no competing interests.

Figures

Figure 1:
Figure 1:
Graphical representation showing the confounding effect of host genetics on the potential causal relationship between RSV infection in infancy and childhood asthma. (1A) Prior studies in this field have focused exclusively on severe RSV infection (usually defined as the presence vs. absence of RSV bronchiolitis requiring hospitalization) in infancy with childhood asthma (a) and have thus lacked a true control group of children without RSV infection in infancy. Furthermore, because both the severity of an RSV infection and the onset of childhood asthma may share a common genetic origin, or an RSV bronchiolitis requiring hospitalization in infancy may simply represent the first acute asthma exacerbation in an otherwise genetically predisposed child, these studies were highly susceptible to confounding by host genetics (b and c). (1B) In the current study, we examined the effect of being uninfected with RSV in infancy on the development of childhood asthma (d) and thus included a true control group of children not infected with RSV in the first year of life. In addition, because RSV is ubiquitous and nearly everyone is infected with it by age 2–3 years, being uninfected vs. infected with RSV in infancy is a natural event and less likely to be associated with host genetics (e). Hence, our study design is likely to mitigate confounding by shared genetic susceptibility. Definition of abbreviations: RSV = Respiratory syncytial virus.
Figure 2:
Figure 2:
Flow diagram of the hierarchical algorithm used for the classification of RSV infection in infancy. The number (%) of eligible children enrolled in the study with RSV infection in infancy and 5-year current asthma are also shown. Definition of abbreviations: INSPIRE = Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study, RSV = Respiratory syncytial virus, RT-qPCR = Reverse transcription-quantitative polymerase chain reaction.
Figure 3:
Figure 3:
The association of being uninfected with RSV in infancy with the primary and secondary outcomes. The bar plots show the % of children with 5-year current asthma (3A), recurrent wheeze (3B) at each of the measured timepoints, and 5-year current asthma inflammatory subtype ascertained using evidence of aeroallergen sensitization by skin prick testing or blood specific IgE testing at age 3 years (3C) in children infected and uninfected with RSV in infancy. The p-values shown for the comparison between groups were calculated using chi-squared tests. The number of children with each outcome and the total number of children for each group are shown inside the bars. Definition of abbreviations: RSV = Respiratory syncytial virus,
Figure 4:
Figure 4:
Predicted probability of recurrent wheeze over the first 4 years of life by RSV infection in infancy. The solid lines represent the predicted probability for each group. The adjacent shaded bands represent the corresponding lower and upper 95% CIs. The estimates were obtained from a generalized estimating equation regression model with a Poisson random component and log link for repeated measures (using an independent working correlation) and correcting covariance matrices using the Huber-White robust sandwich method. The model included the child’s sex, race and ethnicity, ever breastfeeding, daycare attendance in infancy, exposure to secondhand smoking in utero or in early infancy, and maternal asthma as covariates. Definition of abbreviations: CI = Confidence interval, RSV = Respiratory syncytial virus.

Comment in

References

    1. Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 2022. - PMC - PubMed
    1. Driscoll AJ, Arshad SH, Bont L, et al. Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting. Vaccine 2020. - PMC - PubMed
    1. Hartert TV, Wu P, Brunwasser SM. Respiratory syncytial virus and asthma: untying the Gordian knot. The Lancet Respiratory medicine 2021; 9(10): 1092–4. - PubMed
    1. Brunwasser SM, Snyder BM, Driscoll AJ, et al. Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis. The Lancet Respiratory medicine 2020; 8(8): 795–806. - PMC - PubMed
    1. Wittig HJ, Glaser J. The relationship between bronchiolitis and childhood asthma; a follow-up study of 100 cases of bronchiolitis. J Allergy 1959; 30(1): 19–23. - PubMed

Publication types